GSK plc
XETRA:GS71
GSK plc
XETRA:GS71
Price:
24.83
EUR
0.2%
Market Cap:
€101.3B
Relative Value
The Relative Value of one
GS71
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 24.83 EUR,
GSK plc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
GS71 Relative Value
HIDDEN
Multiples Across Competitors
GS71 Competitors Multiples
GSK plc Competitors
GSK plc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
|
GSK plc
XETRA:GS71
|
101.2B EUR | 2.7 | 15.4 | 7.8 | 11.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
972.6B USD | 14.9 | 47 | 31.7 | 33.7 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
575B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
281.9B CHF | 4.6 | 29.9 | 12.6 | 14.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
226.9B GBP | 5.4 | 33.6 | 16 | 23.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
235.6B CHF | 5.4 | 21.7 | 13.4 | 17.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
291.8B USD | 4.5 | 16.1 | 10.1 | 11.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.4 | 13.2 | 9.7 | 11.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.9B USD | 2.5 | 20.3 | 7.5 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.8B USD | 2.6 | 17.5 | 6.8 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
